Aflibercept for the treatment of neovascular age-related macular degeneration.

@article{VernerCole2012AfliberceptFT,
  title={Aflibercept for the treatment of neovascular age-related macular degeneration.},
  author={Elizabeth A Verner-Cole and Steven J Davis and Andreas Katsuya Lauer},
  journal={Drugs of today},
  year={2012},
  volume={48 5},
  pages={317-29}
}
Age-related macular degeneration (AMD) can have devastating effects on vision, especially in its neovascular form. In the last decade, the use of intravitreal pharmacotherapy targeted to vascular endothelial growth factor (VEGF) has significantly improved the visual outcomes in patients with neovascular AMD. Although we have become accustomed to these unprecedented improvement outcomes, maintaining good visual results with anti-VEGF therapy requires tremendous effort, time and cost, typically… CONTINUE READING
Highly Cited
This paper has 28 citations. REVIEW CITATIONS
8 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…